Antiretroviral Improvement Among Medicaid Enrollees - Trial NCT05477485
Access comprehensive clinical trial information for NCT05477485 through Pure Global AI's free database. This phase not specified trial is sponsored by Virginia Commonwealth University and is currently Not yet recruiting. The study focuses on Human Immunodeficiency Virus. Target enrollment is 1040 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Antiretroviral Improvement among Medicaid enrolleeS (patient)
Interventional
behavioral
Sponsor & Location
Virginia Commonwealth University
Timeline & Enrollment
N/A
Nov 01, 2022
May 01, 2024
Primary Outcome
HIV viral load
Summary
This study will evaluate whether a new program will affect how often human immunodeficiency
 virus (HIV) antiretroviral therapy (ART) prescriptions are filled and whether the program
 improves the health of people living with HIV.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05477485
Non-Device Trial